2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2022-8-4-0-32891Genetics<strong>Association of the rs10508336 polymorphism of the <em>TAF3</em> transcription factor gene with the risk of lower limb arterial disease in the Russian population</strong><br /> &nbsp;<strong>Association of the rs10508336 polymorphism of the <em>TAF3</em> transcription factor gene with the risk of lower limb arterial disease in the Russian population</strong><br /> &nbsp;ZhabinSergey N.ZhabinSergey N.79038771993@yandex.ru20228400

Background:&nbsp;Atherosclerosis obliterans (AO) and diabetic angiopathy (DA) are known to be peripheral artery diseases (PAD) of multifactorial origin, in which genetic and environmental factors play a synergetic role. TAF3 is one of the genes that has been found to be associated with PAD. The aim of the study:&nbsp;To analyze the association of the rs10508336 polymorphism of the TAF3 gene with the risk of PAD in the Russian population. Materials and methods:&nbsp;The study involved 1261 patients, including 642 healthy subjects and 619 PAD patients. All patients were recruited at the Vascular Surgery Division of the Kursk Regional Clinical Hospital. Isolation of genomic DNA was carried out by chloroform extraction and precipitation with ethanol. Genotyping was carried out on the basis of the Research Institute of Genetic and Molecular Epidemiology of KSMU using a MassARRAY-4 time-of-flight genomic mass spectrometer (Agena Bioscience, USA). Results:&nbsp;We found that polymorphism rs10508336 is associated with an increased risk of developing bilateral peripheral atherosclerosis exclusively in smokers (P&lt;0.05).&nbsp;The polymorphism was found to be statistically significantly associated with an increased risk of DA (OR=1.59, 95% CI 1.02-2.46, P=0.045). Furthermore, an association of the rs10508336-A allele with an increase in blood glucose levels in PAD was observed (P=0.01). Conclusion:&nbsp;In the Russian population, an association of the rs10508336 polymorphism of the TAF3 gene with an increased risk of AO, hyperglycemia, and diabetic angiopathy was revealed for the first time. The identified associations point out a possible relationship between carbohydrate metabolism and atherosclerotic processes in the determination of peripheral arterial diseases.

Background:&nbsp;Atherosclerosis obliterans (AO) and diabetic angiopathy (DA) are known to be peripheral artery diseases (PAD) of multifactorial origin, in which genetic and environmental factors play a synergetic role. TAF3 is one of the genes that has been found to be associated with PAD. The aim of the study:&nbsp;To analyze the association of the rs10508336 polymorphism of the TAF3 gene with the risk of PAD in the Russian population. Materials and methods:&nbsp;The study involved 1261 patients, including 642 healthy subjects and 619 PAD patients. All patients were recruited at the Vascular Surgery Division of the Kursk Regional Clinical Hospital. Isolation of genomic DNA was carried out by chloroform extraction and precipitation with ethanol. Genotyping was carried out on the basis of the Research Institute of Genetic and Molecular Epidemiology of KSMU using a MassARRAY-4 time-of-flight genomic mass spectrometer (Agena Bioscience, USA). Results:&nbsp;We found that polymorphism rs10508336 is associated with an increased risk of developing bilateral peripheral atherosclerosis exclusively in smokers (P&lt;0.05).&nbsp;The polymorphism was found to be statistically significantly associated with an increased risk of DA (OR=1.59, 95% CI 1.02-2.46, P=0.045). Furthermore, an association of the rs10508336-A allele with an increase in blood glucose levels in PAD was observed (P=0.01). Conclusion:&nbsp;In the Russian population, an association of the rs10508336 polymorphism of the TAF3 gene with an increased risk of AO, hyperglycemia, and diabetic angiopathy was revealed for the first time. The identified associations point out a possible relationship between carbohydrate metabolism and atherosclerotic processes in the determination of peripheral arterial diseases.

peripheral artery diseasediabetic angiopathygenetic predispositionsingle nucleotide polymorphismTAF3smokingperipheral artery diseasediabetic angiopathygenetic predispositionsingle nucleotide polymorphismTAF3smokingСписок литературыLu Y, Thavarajah T, Gu W, et al. Impact of miRNA in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018;38(9):159-170. DOI: https://doi.org/10.1161/ATVBAHA.118.310227GWAS Catalog [Internet] [cited 2022 Feb 15]. Available from: https://www.ebi.ac.uk/gwas/homeBennett MR, Sinha S, Owens GK. Vascular Smooth Muscle Cells in Atherosclerosis. Circulation Research. 2016;118(4):692-702. DOI: https://doi.org/10.1161/CIRCRESAHA.115.306361Xu S, Pelisek J, Jin ZG. Atherosclerosis Is an Epigenetic Disease. Trends in Endocrinology and Metabolism. 2018;29(11):739-742. DOI: https://doi.org/10.1016/j.tem.2018.04.007van Nuland R, Schram AW, van Schaik FMA, et al. Multivalent engagement of TFIID to nucleosomes. PLoS ONE. 2013;8(9):e73495. DOI: https://doi.org/10.1371/journal.pone.0073495Ward-Caviness CK, Neas LM, Blach C, et al. Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease. PLoS ONE. 2016;11(4):e0152670. DOI: https://doi.org/10.1371/journal.pone.0152670Hueso M, De Ramon L, Navarro E, et al. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-&kappa;B/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis. Atherosclerosis. 2016;255:80-89. DOI: https://doi.org/10.1016/j.atherosclerosis.2016.11.002Liu Y, Sun Y, Hu C, et al. Perivascular Adipose Tissue as an Indication, Contributor to, and Therapeutic Target for Atherosclerosis. Frontiers in Physiology. 2020;11:615503. DOI: https://doi.org/10.3389/fphys.2020.615503Azarova IE, Klyosova EYu, Sakali SYu, et al. Contribution of rs11927381 polymorphism of the IGF2BP2 gene to the pathogenesis of type 2 diabetes. Research Results in Biomedicine. 2020;6(1):9-19. Russian. DOI: https://doi.org/10.18413/2658-6533-2020-6-1-0-2Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological Reviews. 2004;84(3):767-801. DOI: https://doi.org/10.1152/physrev.00041.2003Kim HW, Shi H, Winkler MA, et al. Perivascular Adipose Tissue and Vascular Perturbation/Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020;40(11):2569-2576. DOI: https://doi.org/10.1161/ATVBAHA.120.312470Mancio J, Oikonomou EK, Antoniades C. Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104(20):1654-1662. DOI: http://dx.doi.org/10.1136/heartjnl-2017-312324Stijf-Bultsma Y, Sommer L, Tauber M, et al. The basal transcription complex component TAF3 transduces changes in nuclear phosphoinositides into transcriptional output. Molecular Cell. 2015;58(3):453-67. DOI: https://doi.org/10.1016/j.molcel.2015.03.009Durrant TN, Hers I. PI3K inhibitors in thrombosis and cardiovascular disease. Clinical and Translational Medicine. 2020;9(1):8. DOI: https://doi.org/10.1186/s40169-020-0261-6Ghigo A, Perino A, Hirsch E. Phosphoinositides and cardiovascular diseases. Current Topics in Microbiology and Immunology. Springer, Dordrecht; 2012:43-60. DOI: https://doi.org/10.1007/978-94-007-5025-8_2Higashi Y, Gautam S, Delafontaine P, et al. IGF-1 and cardiovascular disease. Growth Hormone and IGF Research. 2019;45:6-16. DOI: https://doi.org/10.1016/j.ghir.2019.01.002Hoeflich A, David R, Hjortebjerg R. Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies. Frontiers in Endocrinology. 2018;9:388. DOI: https://doi.org/10.3389/fendo.2018.00388Sadowitz B, Seymour K, Gahtan V, et al. The role of hyaluronic acid in atherosclerosis and intimal hyperplasia. Journal of Surgical Research. 2012;173(2):63-72. DOI: https://doi.org/10.1016/j.jss.2011.09.025Ross S, Gerstein H, Par&eacute; G. The Genetic Link Between Diabetes and Atherosclerosis. Canadian Journal of Cardiology. 2018;34(5):565-574. DOI: https://doi.org/10.1016/j.cjca.2018.01.016Poznyak A, Grechko AV, Poggio P, et al. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. International Journal of Molecular Sciences. 2020;21(5):1835. DOI: https://doi.org/10.3390/ijms21051835Haas AV, McDonnell ME. Pathogenesis of Cardiovascular Disease in Diabetes. Endocrinol Metab Clin North Am. 2018;47(1):51-63. DOI: https://doi.org/10.1016/j.ecl.2017.10.010